Table 3.
Results of the EORTC QLQ-HN35 for head and neck cancer survivors. A comparison of the head and neck cancer patients with a report from the Swedish population [3]
| Symptom scales/items | Oral cancer (n = 51) |
Nasopharyngeal cancer (n = 24) |
Oropharyngeal cancer (n = 15) |
Hypopharyngeal cancer (n = 10) |
Laryngeal cancer (n = 10) |
Thyroid cancer (n = 17) |
Total (n = 127) |
Published Reference norm values (n = 562) |
p1 | Published Head and neck cancer survivors (n = 133) |
p2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
| Pain | 10.13 (18.66) | 6.60 (12.03) | 11.67 (26.50) | 4.17 (8.10) | 7.5 (10.72) | 3.92 (8.90) | 8.14 (16.52) | 3.0 (9.4) | < 0.01 | 14.5 (19.8) | < 0.01 |
| Swallowing | 9.80 (17.46) | 9.72 (25.38) | 18.33 (24.44) | 8.33 (15.71) | 14.17 (22.59) | 6.37 (11.98) | 10.56 (19.71) | 2.0 (7.2) | < 0.01 | 10.9 (19.6) | 0.9 |
| Sense problems | 7.19 (18.33) | 18.06 (25.97) | 22.22 (24.13) | 16.67 (19.25) | 21.67 (32.44) | 1.96 (5.54) | 12.21 (21.87) | 5.8 (16.1) | < 0.01 | 20.5 (27.4) | < 0.01 |
| Speech problems | 12.20 (19.41) | 8.33 (15.46) | 20 (25.27) | 1.11 (19.91) | 15.56 (28.30) | 8.50 (8.36) | 11.29 (19.50) | 6.1 (13.2) | < 0.01 | 12.1 (19.1) | 0.73 |
| Trouble with social eating | 17.81 (27.64) | 12.15 (21.14) | 27.22 (30.78) | 12.5 (20.88) | 10.83 (26.07) | 2.94 (10.18) | 14.90 (25.04) | 2.7 (10.0) | < 0.01 | 11.7 (22.6) | 0.28 |
| Trouble with social contact | 9.15 (18.81) | 4.72 (11.37) | 2.67 (6.07) | 2.67 (4.66) | 10.67 (24.78) | 3.92 (5.80) | 6.46 (15.05) | 3.8 (10.6) | 0.05 | 7.6 (14.7) | 0.55 |
| Less sexuality | 12.75 (36.15) | 11.11 (37.64) | 31.11 (47.50) | 6.67 (25.09) | 10 (30.63) | 10.78 (42.06) | 13.65 (37.53) | 26.1 (33.6) | < 0.01 | 28.8 (36.3) | < 0.01 |
| Dental problems | 32.68 (36.20) | 27.78 (28.94) | 20 (35.19) | 43.33 (44.58) | 23.33 (31.62) | 13.73 (20.62) | 27.82 (33.80) | 10.1 (21.4) | < 0.01 | 21.4 (32.3) | 0.12 |
| Mouth opening | 32.68 (36.20) | 27.78 (28.94) | 20 (35.19) | 43.33 (44.58) | 23.33 (31.62) | 13.73 (20.62) | 27.82 (33.80) | 1.8 (10.8) | < 0.01 | 17.6 (29.3) | < 0.01 |
| Dry mouth | 30.07 (39.58) | 16.67 (26.01) | 31.11 (36.66) | 10 (22.50) | 16.67 (32.39) | 1.96 (8.09) | 21.26 (33.51) | 12.3 (22.3) | < 0.01 | 47.3 (36.3) | < 0.01 |
| Sticky saliva | 37.25 (38.09) | 33.33 (31.08) | 42.22 (36.66) | 36.67 (39.91) | 33.33 (31.43) | 25.49 (27.71) | 35.17 (34.71) | 6.9 (17.5) | < 0.01 | 18.6 (28.4) | < 0.01 |
| Coughing | 20.92 (31.24) | 31.94 (34.72) | 53.33 (35.18) | 23.33 (35.31) | 20 (32.20) | 13.73 (26.51) | 25.98 (33.57) | 16.8 (24.4) | < 0.01 | 17.3 (24.6) | 0.02 |
| Malaise | 17.65 (27.77) | 18.06 (29.45) | 24.44 (40.76) | 20 (32.20) | 16.67 (32.39) | 17.65 (17.15) | 18.64 (28.99) | 11.3 (21.5) | < 0.01 | 10.8 (20.0) | 0.01 |
p1 P-value between the study population and the reference norm, p2 P-value between the study population and previously published head and neck cancer survivors